Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011

Obstetrics and Gynecology

Volumn 123, Issue 6, 2014, Pages 1177-1184

  Camelo Castillo, Wendy ^a,b,c   Boggess, Kim ^a   Stürmer, Til ^a   Brookhart, M Alan ^a   Benjamin, Daniel K ^a   Jonsson Funk, Michele ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c GEISINGER HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; INSULIN;

ADOLESCENT; ADULT; AGE; ARTICLE; AVERAGE; BIOMETRY; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GESTATIONAL AGE; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; GROUPS BY AGE; HEALTH CARE; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; HYPERANDROGENISM; HYPOTHYROIDISM; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; MANAGEMENT; MATERNAL AGE; METABOLIC SYNDROME X; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROCEDURES; RESEARCH; RETROSPECTIVE STUDY; RISK; RISK MANAGEMENT; SEX; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; COMORBIDITY; DIABETES, GESTATIONAL; FEMALE; GLYBURIDE; HUMANS; HYPERANDROGENISM; HYPOGLYCEMIC AGENTS; HYPOTHYROIDISM; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84901641139     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000285     Document Type: Article

References (28)

1. Falavigna M. Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment. Diabetes Res Clin Pract 2012;98:396-405.
2. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004;27(suppl 1):S88-90.
3. Lawrence JM, Andrade SE, Avalos LA, Beaton SJ, Chiu VY, Davis RL, et al. Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007. Obstet Gynecol 2013;121:106-14.
4. Devlieger R, Casteels K, Van Assche FA. Reduced adaptation of the pancreatic B cells during pregnancy is the major causal factor for gestational diabetes: current knowledge and metabolic effects on the offspring. Acta Obstet Gynecol Scand 2008;87:1266-70.
5. Kraemer J, Klein J, Lubetsky A, Koren G. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol 2006;195:270-4.
6. Koren G. Glyburide and fetal safety; transplacental pharmacokinetic considerations. Reprod Toxicol 2001;15:227-9.
7. Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009;85:607-14.
8. Goetzl L, Wilkins I. Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis. J Perinatol 2002;22:403-6.
9. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8.
10. Ogunyemi D, Jesse M, Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract 2007;13:427-8.
11. Bertini AM. Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med 2005;33:519-23.
12. Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 2005;193:118-24.
13. Ramos GA, Jacobson GF, Kirby RS, Ching JY, Field DR. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. J Perinatol 2007;27: 262-7.
14. Coetzee EJ. The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Pract 1985-1986;1:281-7.
15. Waugh N, Royle P, Clar C, Henderson R, Cummins E, Hadden D, et al. Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee. Health Technol Assess 2010;14:1-183.
16. Nicholson W, Bolen S, Witkop CT, Neale D, Wilson L, Bass E. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol 2009;113:193-205.
17. Hansen LG, Chang S. Health research data for the real world: the MarketScan databases. A white paper. Ann Arbor (MI); Truven Health Analytics; 2012.
18. Clegg LX. Estimating average annual per cent change in trend analysis. Stat Med 2009;28:3670-82.
19. Royston P, Sauerbrei W. Mutivariable model building: a pragmatic approach to regression analysis based on fractional polynomials for continuous variables. West Sussex (UK): John Wiley & Sons Ltd; 2008.
20. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol 2004;104:88-93.
21. Ogunyemi DA, Fong A, Rad S, Fong S, Kjos SL. Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG). Diabet Med 2011;28:976-86.
22. Yogev Y. Glyburide in gestational diabetes-prediction of treatment failure. J Matern Fetal Neonatal Med 2011;24:842-6.
23. Rochon M. Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes. Am J Obstet Gynecol 2006;195:1090-4.
24. Kahn BF, Davies JK, Lynch AM, Reynolds RM, Barbour LA. Predictors of glyburide failure in the treatment of gestational diabetes. Obstet Gynecol 2006;107:1303-9.
25. Chmait R, Dinise T, Moore T. Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol 2004;24:617-22.
26. Gilson G, Murphy N. Comparison of oral glyburide with insulin for the management of gestational diabetes mellitus in Alaska native women. Am J Obstet Gynaecol 2012;187 (Suppl 1):336.
27. Andrade SE. Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy. Pharmacoepidemiol Drug Saf 2011;20:1168-76.
28. Albrecht SS, Kuklina EV, Bansil P, Jamieson DJ, Whiteman MK, Kourtis AP, et al. Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care 2010;33:768-73.